Liquid Biopsy

Patients with neuroendocrine tumours (NETs) can access cutting-edge treatments and research technology thanks to a new partnership between doctors and scientists

Cancer treatment is largely based on where it originates in the body, but when a primary site can’t be found, genomics is helping guide diagnosis and treatment for cancers of unknown origin

With the COVID-19 pandemic highlighting the importance of testing, and our capacity to undertake it at large scale, can we use these testing strategies for earlier diagnosis of cancer?

A simple blood test is set to replace painful, invasive biopsies for blood cancer patients